The intersection of infant substance exposure, foster care placement & child welfare policy

Abigail Novak1, Colleen K Gutman2, Vitoria De Francisco Lopes1

  • 1Department of Criminal Justice & Legal Studies, University of Mississippi, Oxford, MS, USA.

PubMed

Insights

Out-of-home placement for infants exposed to substances may harm development. Child welfare systems should consider alternatives to out-of-home placement to improve outcomes for these vulnerable children.

Area of Science:

  • Child Development
  • Public Health Policy
  • Social Work

Background:

  • Fetal exposure laws often mandate child welfare system involvement for substance-exposed infants.
  • Research on the developmental consequences of child welfare system involvement for these infants is limited.

Purpose of the Study:

  • To examine the impact of out-of-home placement on substance-exposed infants at 18 and 36 months.
  • To assess the association between early out-of-home placement and developmental outcomes.

Main Methods:

  • Utilized data from the National Survey of Child and Adolescent Well-being II (NSCAWII).
  • Analyzed a sample of infants (<1 year) referred for substance exposure between Feb 2008-April 2009.
  • Employed propensity score weighting to evaluate the effects of out-of-home placement.

Main Results:

  • Out-of-home placement for substance-exposed infants was associated with increased risk of negative developmental outcomes.
  • Compared to in-home care, out-of-home placement showed potential detriments in attachment, behavior, and development at 18 and 36 months.

Conclusions:

  • Social workers and practitioners should explore alternatives to out-of-home placement for substance-exposed infants.
  • Policies guiding testing and placement decisions may improve developmental trajectories for these children.

Related Concept Videos

Specialized Care Centers and Settings-I01:30

Specialized Care Centers and Settings-I

Specialized care settings or centers are situated in convenient locations within the community and offer care to a specific group or population. They consist of daycare facilities, mental health facilities, rural health facilities, educational institutions, industries, shelters for the homeless, and rehabilitation facilities.
Daycare centers
They provide several functions. Some facilities care for healthy newborns and children whose parents work, while others are medically focused and care for...
1.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Attachment01:20

Attachment

Attachment is vital for infant development, as warm social interactions support growth and well-being. In a classic 1958 study by Harry Harlow, the significance of warmth and comfort in forming attachments was examined. Harlow separated newborn monkeys from their mothers and provided two artificial "mothers": one made of cold wire and the other covered in soft cloth. Despite the wire mother offering food, the infant monkeys preferred the comfort of the cloth mother, demonstrating that...
504